Cargando…
IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models
Chronic hepatitis B virus (HBV) infection causes hepatitis, liver cirrhosis and hepatocellular carcinoma. Covalently closed circular DNA (cccDNA) is the sole viral transcription template and not affected by current treatment options, constituting a key determinant of HBV persistence. Novel therapeut...
Autores principales: | Shen, Zhongliang, Liu, Jing, Wu, Jingwen, Zhu, Yuanfei, Li, Gaiyun, Wang, Jun, Luo, Mengjun, Deng, Qiang, Zhang, Jiming, Xie, Youhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587353/ https://www.ncbi.nlm.nih.gov/pubmed/31281514 http://dx.doi.org/10.7150/thno.35331 |
Ejemplares similares
-
Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance
por: Shen, Zhongliang, et al.
Publicado: (2017) -
Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection
por: Shen, Zhongliang, et al.
Publicado: (2020) -
High mobility group AT-hook 1 (HMGA1) is an important positive regulator of hepatitis B virus (HBV) that is reciprocally upregulated by HBV X protein
por: Shen, Zhongliang, et al.
Publicado: (2022) -
Short-term intratracheal use of PEG-modified IL-2 and glucocorticoid persistently alleviates asthma in a mouse model
por: Wu, Kefei, et al.
Publicado: (2016) -
Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection
por: Thimme, Robert, et al.
Publicado: (2001)